Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Retrosi, C; Vezzoni, R; Conforti, C; Corneli, P; Magaton-Rizzi, G; Zalaudek, I; Di, Meo, N.
Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine.
Acta Dermatovenerol Alp Pannonica Adriat. 2019; 28(4): 185-186.
Doi: 10.15570/actaapa.2019.44
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Zalaudek Iris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The cutaneous adverse effects of gemcitabine include allergic skin rash frequently associated with pruritus, alopecia, sweating, dermatitis with boils, and ulcerations. We report the case of a patient that developed inflammation of seborrheic keratoses after gemcitabine treatment.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adenocarcinoma of Lung - drug therapy
-
Aged - administration & dosage
-
Antimetabolites, Antineoplastic - adverse effects, therapeutic use
-
Deoxycytidine - adverse effects, analogs & derivatives, therapeutic use
-
Drug Eruptions - etiology
-
Female - administration & dosage
-
Humans - administration & dosage
-
Keratosis, Seborrheic - chemically induced
- Find related publications in this database (Keywords)
-
gemcitabine
-
seborrheic keratoses
-
drug adverse reaction